161 related articles for article (PubMed ID: 37341158)
1. Prognostic implications of the extent of downstaging after neoadjuvant therapy for oesophageal adenocarcinoma and oesophageal squamous cell carcinoma.
Kamarajah SK; Markar SR; Low D; Phillips AW
BJS Open; 2023 May; 7(3):. PubMed ID: 37341158
[TBL] [Abstract][Full Text] [Related]
2. Significance of Neoadjuvant Downstaging in Carcinoma of Esophagus and Gastroesophageal Junction.
Kamarajah SK; Navidi M; Wahed S; Immanuel A; Hayes N; Griffin SM; Phillips AW
Ann Surg Oncol; 2020 Sep; 27(9):3182-3192. PubMed ID: 32201923
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant chemoradiotherapy or chemotherapy alone for oesophageal cancer: population-based cohort study.
Kamarajah SK; Phillips AW; Ferri L; Hofstetter WL; Markar SR
Br J Surg; 2021 Apr; 108(4):403-411. PubMed ID: 33755097
[TBL] [Abstract][Full Text] [Related]
4. Outcome of neoadjuvant therapies for cancer of the oesophagus or gastro-oesophageal junction based on a national data registry.
Klevebro F; Lindblad M; Johansson J; Lundell L; Nilsson M
Br J Surg; 2016 Dec; 103(13):1864-1873. PubMed ID: 27689845
[TBL] [Abstract][Full Text] [Related]
5. Nodal Downstaging of Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy: Survival Analysis if ypN0 Is Achieved.
Tang H; Tan L; Wang H; Shen Y; Yin J
J Gastrointest Surg; 2020 Jul; 24(7):1469-1476. PubMed ID: 31346888
[TBL] [Abstract][Full Text] [Related]
6. Analysis of trimodal and bimodal therapy in a selective-surgery paradigm for locally advanced oesophageal squamous cell carcinoma.
Zhou N; Mitchell KG; Corsini EM; Truong VTT; Antonoff MB; Mehran RJ; Rajaram R; Rice DC; Roth JA; Sepesi B; Swisher SG; Vaporciyan AA; Walsh GL; Ajani JA; Hofstetter WL
Br J Surg; 2021 Oct; 108(10):1207-1215. PubMed ID: 34095952
[TBL] [Abstract][Full Text] [Related]
7. Survival after neoadjuvant chemoradiotherapy and oesophagectomy versus definitive chemoradiotherapy for patients with oesophageal squamous cell carcinoma.
Wang BY; Wu SC; Chen HC; Hung WH; Lin CH; Huang CL; Chen HS
Br J Surg; 2019 Feb; 106(3):255-262. PubMed ID: 30395362
[TBL] [Abstract][Full Text] [Related]
8. Reliability of clinical nodal status regarding response to neoadjuvant chemoradiotherapy compared with surgery alone and prognosis in esophageal cancer patients.
Dijksterhuis WPM; Hulshoff JB; van Dullemen HM; Kats-Ugurlu G; Burgerhof JGM; Korteweg T; Mul VEM; Hospers GAP; Plukker JTM
Acta Oncol; 2019 Nov; 58(11):1640-1647. PubMed ID: 31397195
[No Abstract] [Full Text] [Related]
9. Prognostic impact of neoadjuvant chemoradiation in cT3 oesophageal cancer - A propensity score matched analysis.
Hölscher AH; Bollschweiler E; Bogoevski D; Schmidt H; Semrau R; Izbicki JR
Eur J Cancer; 2014 Nov; 50(17):2950-7. PubMed ID: 25307749
[TBL] [Abstract][Full Text] [Related]
10. Role of neoadjuvant treatment in clinical T2N0M0 oesophageal cancer: results from a retrospective multi-center European study.
Markar SR; Gronnier C; Pasquer A; Duhamel A; Beal H; Théreaux J; Gagnière J; Lebreton G; Brigand C; Meunier B; Collet D; Mariette C;
Eur J Cancer; 2016 Mar; 56():59-68. PubMed ID: 26808298
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant chemoradiotherapy or chemotherapy? A comprehensive systematic review and meta-analysis of the options for neoadjuvant therapy for treating oesophageal cancer.
Deng HY; Wang WP; Wang YC; Hu WP; Ni PZ; Lin YD; Chen LQ
Eur J Cardiothorac Surg; 2017 Mar; 51(3):421-431. PubMed ID: 27694253
[TBL] [Abstract][Full Text] [Related]
12. Multicentre study of neoadjuvant chemotherapy for stage I and II oesophageal cancer.
Bekkar S; Gronnier C; Renaud F; Duhamel A; Pasquer A; Théreaux J; Gagnière J; Meunier B; Collet D; Mariette C;
Br J Surg; 2016 Jun; 103(7):855-62. PubMed ID: 27040445
[TBL] [Abstract][Full Text] [Related]
13. Propensity score analysis of oesophageal cancer treatment with surgery or definitive chemoradiotherapy.
Karran A; Blake P; Chan D; Reid TD; Davies IL; Kelly M; Roberts SA; Crosby T; Lewis WG
Br J Surg; 2014 Apr; 101(5):502-10. PubMed ID: 24615406
[TBL] [Abstract][Full Text] [Related]
14. Impact of postoperative TNM stages after neoadjuvant therapy on prognosis of adenocarcinoma of the gastro-oesophageal junction tumours.
Thomaschewski M; Hummel R; Petrova E; Knief J; Wellner UF; Keck T; Bausch D
World J Gastroenterol; 2018 Apr; 24(13):1429-1439. PubMed ID: 29632424
[TBL] [Abstract][Full Text] [Related]
15. Significance of neoadjuvant downstaging in gastric adenocarcinoma.
Prasad P; Sivaharan A; Navidi M; Fergie BH; Griffin SM; Phillips AW
Surgery; 2022 Aug; 172(2):593-601. PubMed ID: 35400501
[TBL] [Abstract][Full Text] [Related]
16. Impact of perineural invasion as a histopathological prognostic factor in ypStage II/III oesophageal squamous cell carcinoma†.
Hsu PK; Chien LI; Lin CH; Yeh YC; Chuang CY; Hsu HS; Wu YC; Hsu CP
Eur J Cardiothorac Surg; 2019 May; 55(5):927-933. PubMed ID: 30496377
[TBL] [Abstract][Full Text] [Related]
17. Radiation dose and pathological response in oesophageal cancer patients treated with neoadjuvant chemoradiotherapy followed by surgery: a multi-institutional analysis.
Thomas M; Borggreve AS; van Rossum PSN; Perneel C; Moons J; Van Daele E; van Hillegersberg R; Deng W; Pattyn P; Mook S; Boterberg T; Ruurda JP; Nafteux P; Lin SH; Haustermans K
Acta Oncol; 2019 Oct; 58(10):1358-1365. PubMed ID: 31432736
[No Abstract] [Full Text] [Related]
18. Sex differences in the prognosis after surgery for esophageal squamous cell carcinoma and adenocarcinoma.
Kauppila JH; Wahlin K; Lagergren P; Lagergren J
Int J Cancer; 2019 Mar; 144(6):1284-1291. PubMed ID: 30168595
[TBL] [Abstract][Full Text] [Related]
19. Patterns of recurrence in early-stage oesophageal cancer after chemoradiotherapy and surgery compared with surgery alone.
Robb WB; Messager M; Dahan L; Mornex F; Maillard E; D'Journo XB; Triboulet JP; Bedenne L; Seitz JF; Mariette C; ; ; ; ;
Br J Surg; 2016 Jan; 103(1):117-25. PubMed ID: 26511668
[TBL] [Abstract][Full Text] [Related]
20. Stage for stage comparison of recurrence patterns after definitive chemoradiotherapy or surgery for oesophageal carcinoma.
Reid TD; Davies IL; Mason J; Roberts SA; Crosby TD; Lewis WG
Clin Oncol (R Coll Radiol); 2012 Nov; 24(9):617-24. PubMed ID: 22386923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
